S&P 500   4,283.85
DOW   33,573.28
QQQ   354.84
High Dividend REITs: Are They an Ideal Way to Diversify?
Famous Wall Street Crash System Flashes RED (Ad)
Dollar General May Create an Opportunity for Patient Investors
Is Frontline's 20% Dividend Too Good To Be True?
The single greatest medical breakthrough of all time? (Ad)
3 Reasons The Wayfair Rally Is Way Overdone
Wheat prices jump following collapse of major dam in southern Ukraine
The single greatest medical breakthrough of all time? (Ad)
Here’s What’s Driving the Price of Carvana Higher
Stock market today: Asian stocks mixed as Wall St inches toward bull market
S&P 500   4,283.85
DOW   33,573.28
QQQ   354.84
High Dividend REITs: Are They an Ideal Way to Diversify?
Famous Wall Street Crash System Flashes RED (Ad)
Dollar General May Create an Opportunity for Patient Investors
Is Frontline's 20% Dividend Too Good To Be True?
The single greatest medical breakthrough of all time? (Ad)
3 Reasons The Wayfair Rally Is Way Overdone
Wheat prices jump following collapse of major dam in southern Ukraine
The single greatest medical breakthrough of all time? (Ad)
Here’s What’s Driving the Price of Carvana Higher
Stock market today: Asian stocks mixed as Wall St inches toward bull market
S&P 500   4,283.85
DOW   33,573.28
QQQ   354.84
High Dividend REITs: Are They an Ideal Way to Diversify?
Famous Wall Street Crash System Flashes RED (Ad)
Dollar General May Create an Opportunity for Patient Investors
Is Frontline's 20% Dividend Too Good To Be True?
The single greatest medical breakthrough of all time? (Ad)
3 Reasons The Wayfair Rally Is Way Overdone
Wheat prices jump following collapse of major dam in southern Ukraine
The single greatest medical breakthrough of all time? (Ad)
Here’s What’s Driving the Price of Carvana Higher
Stock market today: Asian stocks mixed as Wall St inches toward bull market
S&P 500   4,283.85
DOW   33,573.28
QQQ   354.84
High Dividend REITs: Are They an Ideal Way to Diversify?
Famous Wall Street Crash System Flashes RED (Ad)
Dollar General May Create an Opportunity for Patient Investors
Is Frontline's 20% Dividend Too Good To Be True?
The single greatest medical breakthrough of all time? (Ad)
3 Reasons The Wayfair Rally Is Way Overdone
Wheat prices jump following collapse of major dam in southern Ukraine
The single greatest medical breakthrough of all time? (Ad)
Here’s What’s Driving the Price of Carvana Higher
Stock market today: Asian stocks mixed as Wall St inches toward bull market
NASDAQ:BLU

BELLUS Health (BLU) News Today

$14.60
+0.01 (+0.07%)
(As of 06/6/2023 ET)
Compare
Today's Range
$14.58
$14.62
50-Day Range
$6.46
$14.63
52-Week Range
$6.38
$14.67
Volume
2.18 million shs
Average Volume
3.01 million shs
Market Capitalization
$1.85 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$16.50
Get BELLUS Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for BLU and its competitors with MarketBeat's FREE daily newsletter.



BLU Media Mentions By Week

BLU Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

BLU
News Sentiment

0.00

0.52

Average
Medical
News Sentiment

BLU News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

BLU Articles
This Week

0

2

BLU Articles
Average Week

SourceHeadline
MarketBeat logoBELLUS Health (NASDAQ:BLU) Hits New 52-Week High at $14.60
americanbankingnews.com - May 25 at 7:32 AM
marketbeat.com logoLetko Brosseau & Associates Inc. Buys Shares of 16,000 BELLUS Health Inc. (NASDAQ:BLU)
marketbeat.com - May 19 at 12:08 PM
MarketBeat logoStock Traders Purchase High Volume of Put Options on BELLUS Health (NASDAQ:BLU)
americanbankingnews.com - May 19 at 1:10 AM
marketbeat.com logoShort Interest in BELLUS Health Inc. (NASDAQ:BLU) Decreases By 36.5%
marketbeat.com - May 12 at 8:43 AM
MarketBeat logoBELLUS Health (NASDAQ:BLU) Hits New 52-Week High at $14.54
americanbankingnews.com - May 12 at 6:29 AM
marketbeat.com logoToronto Dominion Bank Lowers Holdings in BELLUS Health Inc. (NASDAQ:BLU)
marketbeat.com - May 12 at 5:00 AM
ca.finance.yahoo.com logoTSX Stocks in the Healthcare Industry: Which Ones Are Worth Your Money?
ca.finance.yahoo.com - May 10 at 6:46 PM
finance.yahoo.com logoShould You Buy Bellus Health (BLU) After Golden Cross?
finance.yahoo.com - May 10 at 1:10 PM
MarketBeat logoBELLUS Health Inc. (NASDAQ:BLU) Short Interest Update
americanbankingnews.com - May 4 at 6:24 AM
theglobeandmail.com logoClosing Bell: Bellus Health Inc up on Tuesday (BLU)
theglobeandmail.com - May 2 at 7:16 PM
theglobeandmail.com logoBELLUS Health: Top 25 Performing Stocks Year-to-Date on Toronto Stock Exchange (BLU)
theglobeandmail.com - April 26 at 7:08 PM
finance.yahoo.com logoBELLUS Health Announces Meeting Updates
finance.yahoo.com - April 26 at 7:08 PM
benzinga.com logoMoore Kuehn Encourages BLU, STSA, RXDX, STSA, and CHRA Investors to Contact Law Firm
benzinga.com - April 21 at 2:43 PM
MarketBeat logoBELLUS Health (NASDAQ:BLU) Stock Rating Lowered by Jefferies Financial Group
americanbankingnews.com - April 21 at 5:16 AM
MarketBeat logoBELLUS Health Inc. (NASDAQ:BLU) Short Interest Up 11.1% in March
americanbankingnews.com - April 20 at 7:32 AM
MarketBeat logoBELLUS Health (NASDAQ:BLU) Downgraded by Evercore ISI
americanbankingnews.com - April 20 at 4:00 AM
MarketBeat logoRoyal Bank of Canada Downgrades BELLUS Health (NASDAQ:BLU) to Sector Perform
americanbankingnews.com - April 20 at 2:14 AM
finance.yahoo.com logoBellus Health (BLU) Stock Up 99% on $2B Buyout Offer From GSK
finance.yahoo.com - April 19 at 1:15 PM
marketbeat.com logoBELLUS Health (NASDAQ:BLU) Downgraded to "Hold" at Jefferies Financial Group
marketbeat.com - April 19 at 8:54 AM
theglobeandmail.com logoGSK’s $2-billion purchase of Bellus delivers second big exit for Montreal’s Bellini family
theglobeandmail.com - April 19 at 8:14 AM
MarketBeat logoBELLUS Health (NASDAQ:BLU) Downgraded to Market Perform at Lifesci Capital
americanbankingnews.com - April 19 at 6:56 AM
reuters.com logoGSK bets $2 bln on Bellus cough drug to soothe pipeline fears
reuters.com - April 19 at 3:14 AM
markets.businessinsider.com logoLifeSci Capital Reaffirms Their Hold Rating on BELLUS Health (BLU)
markets.businessinsider.com - April 18 at 7:50 PM
theglobeandmail.com logoGSK signs deal to buy Canadian drug developer Bellus Health for US$2 billion
theglobeandmail.com - April 18 at 5:12 PM
finance.yahoo.com logoBellus Health Soars 99% As GSK Joins Buyout Bonanza With $2 Billion Deal
finance.yahoo.com - April 18 at 5:12 PM
cnbc.com logoStocks making the biggest moves midday: Southwest Airlines, Goldman Sachs, Bellus Health and more
cnbc.com - April 18 at 2:50 PM
bizjournals.com logoGSK to buy Canadian biopharm firm Bellus Health for $2 billion
bizjournals.com - April 18 at 12:11 PM
finance.yahoo.com logoBellus Health Soars 98% As GSK Joins Buyout Bonanza With $2 Billion Deal
finance.yahoo.com - April 18 at 12:11 PM
finance.yahoo.com logoWhy BELLUS Health Stock Is Rocketing Higher Today
finance.yahoo.com - April 18 at 12:11 PM
finance.yahoo.com logoGSK To Strengthen Specialty Medicines and Respiratory Pipeline With $2B BELLUS Health Acquisition
finance.yahoo.com - April 18 at 9:50 AM
theglobeandmail.com logoClosing Bell: Bellus Health Inc up on Monday (BLU)
theglobeandmail.com - April 10 at 6:39 PM
theglobeandmail.com logoClosing Bell: Bellus Health Inc up on Thursday (BLU)
theglobeandmail.com - April 7 at 7:06 PM
theglobeandmail.com logoTSX Finds Strength at Daily Close, Venture Down on Week
theglobeandmail.com - April 6 at 5:43 PM
finance.yahoo.com logoHere's Why Bellus (BLU) is Poised for a Turnaround After Losing -15.33% in 4 Weeks
finance.yahoo.com - April 6 at 12:43 PM
theglobeandmail.com logoClosing Bell: Bellus Health Inc down on Tuesday (BLU)
theglobeandmail.com - April 5 at 4:36 PM
markets.businessinsider.com logoLifeSci Capital Sticks to Their Buy Rating for BELLUS Health (BLU)
markets.businessinsider.com - April 5 at 3:40 PM
finance.yahoo.com logoBELLUS Health Announces Positive Results from its Phase 1 Bioavailability Equivalence Study Evaluating Once-Daily Extended-Release Formulation of Camlipixant in Comparison to Twice-Daily Immediate Release Formulation
finance.yahoo.com - April 5 at 8:44 AM
marketbeat.com logoBELLUS Health Inc. (NASDAQ:BLU) Shares Bought by National Bank of Canada FI
marketbeat.com - April 5 at 5:28 AM
theglobeandmail.com logoClosing Bell: Bellus Health Inc up on Wednesday (BLU)
theglobeandmail.com - March 30 at 5:40 PM
marketbeat.com logoPendal Group Ltd Has $1.04 Million Stake in BELLUS Health Inc. (NASDAQ:BLU)
marketbeat.com - March 29 at 5:47 AM
marketbeat.com logoAssenagon Asset Management S.A. Trims Stock Holdings in BELLUS Health Inc. (NASDAQ:BLU)
marketbeat.com - March 27 at 4:46 AM
MarketBeat logoHC Wainwright Comments on BELLUS Health Inc.'s Q1 2023 Earnings (NASDAQ:BLU)
americanbankingnews.com - March 26 at 1:30 AM
MarketBeat logoBELLUS Health Inc. to Post Q1 2023 Earnings of ($0.19) Per Share, Jefferies Financial Group Forecasts (NASDAQ:BLU)
americanbankingnews.com - March 26 at 1:30 AM
MarketBeat logoBELLUS Health (NASDAQ:BLU) Stock Price Down 2.4%
americanbankingnews.com - March 25 at 7:38 AM
MarketBeat logoBELLUS Health (NASDAQ:BLU) Earns Outperform Rating from Royal Bank of Canada
americanbankingnews.com - March 25 at 3:41 AM
msn.com logoWall Street Analysts Think Bellus (BLU) Could Surge 156.01%: Read This Before Placing a Bet
msn.com - March 24 at 12:13 PM
marketbeat.com logoHC Wainwright Weighs in on BELLUS Health Inc.'s Q1 2023 Earnings (NASDAQ:BLU)
marketbeat.com - March 24 at 6:33 AM
marketbeat.com logoBELLUS Health (NASDAQ:BLU) Stock Rating Reaffirmed by Royal Bank of Canada
marketbeat.com - March 22 at 9:11 AM
markets.businessinsider.com logoAnalysts Offer Insights on Healthcare Companies: Selecta Biosciences (SELB) and BELLUS Health (BLU)
markets.businessinsider.com - March 22 at 8:54 AM
MarketBeat logoBELLUS Health (NASDAQ:BLU) Given "Buy" Rating at HC Wainwright
americanbankingnews.com - March 22 at 8:18 AM
Get BELLUS Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for BLU and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:BLU) was last updated on 6/7/2023 by MarketBeat.com Staff

My Account -